Statins (cholesterol drugs): examples include lovastatin (Mevacor), atorvastatin (Lipitor), simvastatin (Zocor), simvastatin/ezetimibe combination Interaction: Grapefruit can increase blood levels of these statins, raising the risk of muscle toxicity, known as rhabdomyolysis Safer alternatives include: rosuvastatin (Crestor), fluvastatin (Lescol), pravastatin (Pravachol), Calcium channel blockers (blood pressure drugs): examples include amlodipine (Norvasc), diltiazem (Cardiazem, Tiazac), felodipine (Plendil), nifedipine XL (Adalat XL), verapamil (Isoptin SR, Verelan) Interaction: Increased drug levels may cause hypotension, dizziness or edema Antiarrhythmics (atrial fibrillation drugs): examples include amiodarone (Cordarone), disopyramide (Norpace) Interaction: Increased risk of QT prolongation, arrhythmia and other side effects
Behavioral interventions during and after treatment significantly reduce rebound risk
Gut microbiome dysbiosis across early Parkinson's disease, REM sleep behavior disorder and their first-degree relatives
This was verified with blood safety markers that indicate problems resulting from supplements
(2) Translational Development: Research should accelerate the development of lung-specific delivery platforms (e.g., ligand-functionalized nanoparticles) for targeted ferroptosis intervention, moving from promising preclinical concepts toward clinical application
[] As shown in Figure 4, patients with COVID-19 of all age groups had significantly lower levels of GSH compared with their levels among individuals of Group B